content

CENTOGENE and Ubirch Create Secure Blockchain Solution for the Successful Fight Against COVID-19

CENTOGENE , a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical...

Merck Supports Jenner Institute to Reach First Milestone in Covid-19 Vaccine Manufacturing

Merck, a leading science and technology company, and The Jenner Institute announced that the Jenner Institute has laid the foundation for large-scale production of...

Moderna Gets $483M BARDA Deal for COVID-19 Vaccine

Moderna, a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, has entered an agreement for a commitment of up to $483...

Soligenix Announces Exclusive Licensing Agreement for Novel Vaccine Adjuvant from BTG Specialty Pharmaceuticals

Soligenix, Inc , a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need,...

ABL, Inc. Supports Fill/Finish of SARS-CoV-2 (COVID-19) Vaccine Candidate

Advanced BioScience Laboratories, Inc. (ABL), a global CMDO and Contract Research Organization (CRO) for biotherapeutics, oncolytics and vaccines, a subsidiary of the French bioindustrial...

Roche develops new serology test to detect COVID-19 antibodies

Roche announced the development and upcoming launch of its Elecsys® Anti-SARS-CoV-2 serology test to detect antibodies in people who have been exposed to the...

Sanofi and Luminostics to join forces on developing breakthrough COVID-19 smartphone-based self-testing solution

Sanofi and Luminostics have signed an agreement to evaluate a collaboration on a unique self-testing solution for COVID-19, using Luminostics’ innovative technology, and further...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read